Electropharmacologic testing in sustained ventricular tachycardia associated with coronary heart disease: value of the response to intravenous procainamide in predicting the response to oral procainamide and oral quinidine treatment.

Oseran, D S; Gang, E S; Rosenthal, M E; Mandel, W J; Peter, T

Oseran, D S; Gang, E S; Rosenthal, M E; Mandel, W J; Peter, T.

Am J Cardiol ; 56(13): 883-6, 1985 Nov 15.

Article in En | MEDLINE | ID: mdl-3904387

Subject(s)

Coronary Disease/complications; Procainamide/administration & dosage; Quinidine/administration & dosage; Tachycardia/drug therapy; Administration, Oral; Adult; Aged; Clinical Trials as Topic; Electrophysiology; Female; Heart Ventricles/physiopathology; Humans; Infusions, Parenteral; Male; Middle Aged; Procainamide/blood; Prospective Studies; Quinidine/blood; Random Allocation; Tachycardia/etiology; Tachycardia/physiopathology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Procainamide / Quinidine / Tachycardia / Coronary Disease Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies Aspects: Patient_preference Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Am J Cardiol Year: 1985 Document type: Article Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links